Report Detail
Global Shrimps Disease Diagnostic Market Size, Status and Forecast 2019-2025
- RnM3649867 |
- 06 August, 2019 |
- Global |
- 92 Pages |
- QYResearch |
- Other
Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
Disease problems in shrimp production are poorly understood and diagnosed. Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge. Diagnosis of that disease is very important. There is no therapeutic option available for viral diseases and the only option available to detect and avoid the pathogen entry into culture systems. DNA based diagnostic tool such as PCR used to test. Diagnosis tools and technologies are gaining demand for the quick and effective diagnosis of shrimp diseases for management of disease outbreaks. Assay based kits and rapid test kits are available for the shrimp's disease diagnostic market.
In 2018, the global Shrimps Disease Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Shrimps Disease Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Shrimps Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
GeneReach Biotechnology Corp
pop bio
SUREBIO
Auro Biotechnologies
Market segment by Type, the product can be split into
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Market segment by Application, split into
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Shrimps Disease Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Shrimps Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Shrimps Disease Diagnostic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Shrimps Disease Diagnostic Market Size Growth Rate by Type (2014-2025)
- 1.4.2 WSSV (White Spot Syndrome Virus)
- 1.4.3 TSV (Taura Syndrome Virus)
- 1.4.4 YHV/GAV (Yellow Head/Gill Associated Virus)
- 1.4.5 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
- 1.4.6 HPV (Hepatopancreatic Parvovirus)
- 1.4.7 MBV (Monodon Baculovirus)
- 1.4.8 IMNV (Infectious Myonecrosis Virus)
- 1.4.9 NHP-B (Necrotising Hepatopancreatitis Bacteria)
- 1.4.10 MoV (Mourilyan Virus)
- 1.4.11 Early Mortality Syndrome (EMS)
- 1.5 Market by Application
- 1.5.1 Global Shrimps Disease Diagnostic Market Share by Application (2019-2025)
- 1.5.2 Fisheries
- 1.5.3 Aquaculture Laboratories
- 1.5.4 Marine Laboratories
- 1.5.5 Education and Research Institutes
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Shrimps Disease Diagnostic Market Size
- 2.2 Shrimps Disease Diagnostic Growth Trends by Regions
- 2.2.1 Shrimps Disease Diagnostic Market Size by Regions (2019-2025)
- 2.2.2 Shrimps Disease Diagnostic Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Shrimps Disease Diagnostic Market Size by by Players
- 3.1.1 Global Shrimps Disease Diagnostic Revenue by by Players (2014-2019)
- 3.1.2 Global Shrimps Disease Diagnostic Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Shrimps Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
- 3.2 Shrimps Disease Diagnostic Key Players Head office and Area Served
- 3.3 Key Players Shrimps Disease Diagnostic Product/Solution/Service
- 3.4 Date of Enter into Shrimps Disease Diagnostic Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Shrimps Disease Diagnostic Market Size by Type (2014-2019)
- 4.2 Global Shrimps Disease Diagnostic Market Size by Application (2014-2019)
5 North America
- 5.1 North America Shrimps Disease Diagnostic Market Size (2014-2019)
- 5.2 Shrimps Disease Diagnostic Key Players in North America
- 5.3 North America Shrimps Disease Diagnostic Market Size by Type
- 5.4 North America Shrimps Disease Diagnostic Market Size by Application
6 Europe
- 6.1 Europe Shrimps Disease Diagnostic Market Size (2014-2019)
- 6.2 Shrimps Disease Diagnostic Key Players in Europe
- 6.3 Europe Shrimps Disease Diagnostic Market Size by Type
- 6.4 Europe Shrimps Disease Diagnostic Market Size by Application
7 China
- 7.1 China Shrimps Disease Diagnostic Market Size (2014-2019)
- 7.2 Shrimps Disease Diagnostic Key Players in China
- 7.3 China Shrimps Disease Diagnostic Market Size by Type
- 7.4 China Shrimps Disease Diagnostic Market Size by Application
8 Japan
- 8.1 Japan Shrimps Disease Diagnostic Market Size (2014-2019)
- 8.2 Shrimps Disease Diagnostic Key Players in Japan
- 8.3 Japan Shrimps Disease Diagnostic Market Size by Type
- 8.4 Japan Shrimps Disease Diagnostic Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Shrimps Disease Diagnostic Market Size (2014-2019)
- 9.2 Shrimps Disease Diagnostic Key Players in Southeast Asia
- 9.3 Southeast Asia Shrimps Disease Diagnostic Market Size by Type
- 9.4 Southeast Asia Shrimps Disease Diagnostic Market Size by Application
10 India
- 10.1 India Shrimps Disease Diagnostic Market Size (2014-2019)
- 10.2 Shrimps Disease Diagnostic Key Players in India
- 10.3 India Shrimps Disease Diagnostic Market Size by Type
- 10.4 India Shrimps Disease Diagnostic Market Size by Application
11 Central & South America
- 11.1 Central & South America Shrimps Disease Diagnostic Market Size (2014-2019)
- 11.2 Shrimps Disease Diagnostic Key Players in Central & South America
- 11.3 Central & South America Shrimps Disease Diagnostic Market Size by Type
- 11.4 Central & South America Shrimps Disease Diagnostic Market Size by Application
12 International Players Profiles
- 12.1 HiMedia Laboratories
- 12.1.1 HiMedia Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Shrimps Disease Diagnostic Introduction
- 12.1.4 HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2014-2019))
- 12.1.5 HiMedia Laboratories Recent Development
- 12.2 Speedy Assay Sdn Bhd
- 12.2.1 Speedy Assay Sdn Bhd Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Shrimps Disease Diagnostic Introduction
- 12.2.4 Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.2.5 Speedy Assay Sdn Bhd Recent Development
- 12.3 REAGEN LLC
- 12.3.1 REAGEN LLC Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Shrimps Disease Diagnostic Introduction
- 12.3.4 REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.3.5 REAGEN LLC Recent Development
- 12.4 FUJIKURA KASEI CO., LTD
- 12.4.1 FUJIKURA KASEI CO., LTD Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Shrimps Disease Diagnostic Introduction
- 12.4.4 FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.4.5 FUJIKURA KASEI CO., LTD Recent Development
- 12.5 GeneReach Biotechnology Corp
- 12.5.1 GeneReach Biotechnology Corp Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Shrimps Disease Diagnostic Introduction
- 12.5.4 GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.5.5 GeneReach Biotechnology Corp Recent Development
- 12.6 Thermo Fisher Scientific
- 12.6.1 Thermo Fisher Scientific Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Shrimps Disease Diagnostic Introduction
- 12.6.4 Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.6.5 Thermo Fisher Scientific Recent Development
- 12.7 Lab - Ind Resource Sdn Bhd
- 12.7.1 Lab - Ind Resource Sdn Bhd Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Shrimps Disease Diagnostic Introduction
- 12.7.4 Lab - Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.7.5 Lab - Ind Resource Sdn Bhd Recent Development
- 12.8 AquaBounty Technologies, Inc
- 12.8.1 AquaBounty Technologies, Inc Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Shrimps Disease Diagnostic Introduction
- 12.8.4 AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.8.5 AquaBounty Technologies, Inc Recent Development
- 12.9 GeneReach Biotechnology Corp
- 12.9.1 GeneReach Biotechnology Corp Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Shrimps Disease Diagnostic Introduction
- 12.9.4 GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.9.5 GeneReach Biotechnology Corp Recent Development
- 12.10 pop bio
- 12.10.1 pop bio Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Shrimps Disease Diagnostic Introduction
- 12.10.4 pop bio Revenue in Shrimps Disease Diagnostic Business (2014-2019)
- 12.10.5 pop bio Recent Development
- 12.11 SUREBIO
- 12.12 Auro Biotechnologies
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Shrimps Disease Diagnostic . Industry analysis & Market Report on Shrimps Disease Diagnostic is a syndicated market report, published as Global Shrimps Disease Diagnostic Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Shrimps Disease Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
